Benoit Kabamba to Spike Glycoprotein, Coronavirus
This is a "connection" page, showing publications Benoit Kabamba has written about Spike Glycoprotein, Coronavirus.
Connection Strength
0.027
-
Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis. Am J Kidney Dis. 2021 11; 78(5):766-768.
Score: 0.027